EQUITY RESEARCH MEMO

Antibodies Incorporated

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)60/100

Antibodies Incorporated is a privately held company headquartered in Davis, California, with a long-standing heritage in the antibody and diagnostics industry since 1962. The company specializes in the manufacturing and distribution of monoclonal and polyclonal antibodies, diagnostic reagents, and diagnostic kits, as well as the development and practice of immunoassays. With over six decades of experience, it has established itself as a reliable supplier to the scientific community, supporting research, clinical diagnostics, and biotechnology applications. The company's extensive product portfolio and technical expertise position it as a key player in the antibody market, serving academic institutions, pharmaceutical companies, and clinical laboratories. Looking ahead, Antibodies Incorporated is well-positioned to capitalize on growing demand for antibodies and diagnostic tools, driven by advancements in personalized medicine, immunotherapy, and infectious disease testing. The company's focus on quality and innovation, combined with its established distribution network, provides a solid foundation for sustained growth. However, as a private company, financial details and specific growth initiatives are not publicly disclosed. The company's long track record and reputation in the field suggest resilience and adaptability in a competitive landscape.

Upcoming Catalysts (preview)

  • TBDLaunch of new diagnostic kits for infectious diseases50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)